This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Tracking Adverse Medication Events and Drug:Drug Interactions
January 29, 2019
Breaking Thought Cycles Using Mindfulness
January 29, 2019
Prescribe Happiness to Improve Our Health
January 29, 2019
What Happens When Patients Lead the Health Team?
January 29, 2019
Getting a grip on pain and the brain: Prof Lorimer Moseley
January 29, 2019
All day in hospital
January 29, 2019
How to produce a sputum sample when asked
January 29, 2019
Meet e-Patient Dave: Take control of your illness management
January 29, 2019
What healthcare will look like in 2020: Patient communication
January 29, 2019
How to use nebulised amphotericin
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video